Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination. | Genes Dis | 2023 | 36097543 | PubTator, text mining | PubMed |
| Self-awareness of olfactory dysfunction in elderly individuals without neurodegenerative diseases. | Eur Arch Otorhinolaryngol | 2023 | 36053357 | PubTator, text mining | PubMed |
| COL3A1: Potential prognostic predictor for head and neck cancer based on immune-microenvironment alternative splicing. | Cancer Med | 2023 | 36039012 | PubTator, text mining | PubMed |
| Costimulatory molecule expression profile as a biomarker to predict prognosis and chemotherapy response for patients with small cell lung cancer. | Cancer Immunol Immunother | 2023 | 36002754 | PubTator, text mining | PubMed |
| Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine. | Anal Bioanal Chem | 2023 | 35970970 | PubTator, text mining | PubMed |
| Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression. | Rheumatology (Oxford) | 2023 | 35924962 | PubTator, text mining | PubMed |
| Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor. | Clin Investig Arterioscler | 2023 | 35738949 | PubTator, text mining | PubMed |
| Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas. | Cancer Med | 2023 | 35702880 | PubTator, text mining | PubMed |
| Establishment and external verification of an oxidative stress-related gene signature to predict clinical outcomes and therapeutic responses of colorectal cancer. | Front Pharmacol | 2022 | 36860211 | PubTator, text mining | PubMed |
| Single-cell RNA-seq reveals cellular heterogeneity from deep fascia in patients with acute compartment syndrome. | Front Immunol | 2022 | 36741388 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response. | Front Immunol | 2022 | 36713409 | PubTator, text mining | PubMed |
| Plasma protein profiling analysis in patients with atrial fibrillation before and after three different ablation techniques. | Front Cardiovasc Med | 2022 | 36704472 | PubTator, text mining | PubMed |
| Extracellular vesicles and melanoma: New perspectives on tumor microenvironment and metastasis. | Front Cell Dev Biol | 2022 | 36704194 | PubTator, text mining | PubMed |
| Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas. | Front Immunol | 2022 | 36703985 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis. | Front Oncol | 2022 | 36686830 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| New Insights into Risk Genes and Their Candidates in Multiple Sclerosis. | Neurol Int | 2022 | 36648967 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of miRNAs Targeting TRAF5 in DLBCL Involving in NF-κB Signaling Pathway and Affecting the Apoptosis and Signal Transduction. | Genet Res (Camb) | 2022 | 36619898 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Immune Checkpoint-Related Model in Clear Cell Renal Cell Carcinoma. | Dis Markers | 2022 | 36618968 | PubTator, text mining | PubMed |
| Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia. | Front Nutr | 2022 | 36618700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=24